This process occurs during cancer development, where there is a loss of expression of epithelial-associated molecules like CDH1 and an increase of mesenchymal-associated molecules such as N-cadherin (CDH2), vimentin (VIM), and fibronectin (FN1) [188, 193]. This evidence concerns the gene FN1 and cancer.